it,” he hastens to add. And like Crandall, Brownstein has caught AI
chatbots making strange, unacceptable errors. “I have found it frequently leading me down a
wrong path or quoting studies that sound great — except they don’t exist,” he says. Some experts predict AI will be more conse-
quential for human development than the In- dustrial Revolution. Dr. Abraham Verghese, vice chair of Stanford
University’s medical school, says AI “will over- take every human endeavor, medicine not least among them.” To fully appreciate the potential of AI to cure
what ails healthcare, consider that a 1999 Insti- tute of Medicine study calculated that as many as 98,000 people die every year in hospitals due to preventable “lethal events.” Today, the reality is far worse. In 2013, a sys-
tematic review published in the Journal of Pa- tient Safety put the actual annual number of avoidable hospital deaths at 440,000. That’s out of about 34 million patients admitted to hospi- tals annually. “What’s wrong in healthcare today,” writes
cardiologist Topol in his bestselling book Deep Medicine, “is care. That is, we generally as doc- tors don’t get to really care for patients enough.” Brownstein agrees, and that’s one reason why
all notes on patient encounters in his practice are handwritten — it keeps the doctor’s eyes on the patient rather than on a computer screen. Of U.S. healthcare, Brownstein laments, “We
finish last in nearly every health indicator, yet we spend the most on healthcare.” He’s right. Each year, the Commonwealth
Fund compares health outcomes in 10 developed nations: Australia, Canada, France, Germany, the Netherlands, New Zealand, Sweden, Switzer- land, the United Kingdom, and the United States. Keep in mind, U.S. per capita healthcare
spending is about twice that of other developed nations. Yet each year, it’s ranked near the bot- tom in multiple categories. Life expectancy is currently about 79 years of
age. That leaves the United States ranked 49th among all nations — and trailing its Western peers. Based on current trends including rising obe-
sity, the U.S. rating is projected to fall to 66th by 2050. Critics blame price inflation, unequal ac- cess, disparities in healthcare quality, and a lack of accountability and oversight. All of which indicates there is a growing real-
ization that U.S. healthcare is in desperate need of resuscitation just as AI is emerging to grab the spotlight. Los Angeles health-tech entrepre- neur Steve Brown found out about
In 2013, a systematic review published in the Journal of Patient Safety put the actual annual number of avoidable hospital deaths at 440,000. That’s out of about 34 million patients admitted to hospitals annually.
Can AI Help You Lose Weight? A
healthier, slimmer you may now be within
reach, all thanks to artificial intelligence (AI). According to a 2024 Kaiser
Foundation survey, one in eight Americans have already tried GLP-1 weight loss drugs such as Wegovy and Ozempic. Doctors hail those trendy drugs as potential lifesavers able to lower blood sugar, aid weight loss, and even fight fatty liver disease. The peptide-based injections also help protect
50 NEWSMAX | NOVEMBER 2025
cardiovascular patients from heart attacks and strokes. But for all their benefits, GLP- 1 drugs also can have serious side effects: anxiety, nausea, vomiting, pancreatitis, and vision problems, to name only a few. They’re also expensive, not always covered by insurance, and require regular injections. By using AI to discover
plant-based alternatives, researchers now hope to find natural compounds that imitate the blood sugar-lowering effects
of GLP-1 medications. And those alternatives, they say, could be taken orally, rather than by injection. AI-equipped researchers
have now screened over 10,000 candidate compounds, identifying two promising natural alternatives. Known as Compound A and Compound B, researchers consider them strong candidates for future development and trials. Could these natural GLP-1
alternatives mark the beginning
of the end of America’s obesity epidemic? One AI researcher noted
hopefully, “Drugs that aren’t peptides may have fewer side effects, and will be easier to administer.” — D.P.
HEALTH REVOLUTION IS HERE
ANDRESR©ISTOCK
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112
